Serentis develops medical products and drugs.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Cambridge
State: Cambridgeshire
Zip:
Country: United Kingdom
Serentis develops medical products and drugs. Its products include SRD441, a novel compound that targets endogenous pro-inflammatory and staphylococcus aureus-derived proteases; and SRD174, a topical product designed to produce relief of pruritus. The company’s research programs include SRD326, a topically-applied product for relief from symptoms of Raynaud’s phenomenon; and SRD285 which provides an approach to wound care, promoting enhanced wound healing and local analgesia. Serentis was founded in 2006 and is based in Cambridge, United Kingdom.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2007 | Series A | 3 | $20.5M |
Apposite Capital MVM Life Science Partners Novo Holdings Apposite Capital MVM Life Science Partners Novo Holdings |
8/2008 | Series A | 4 | $10.1M |
Apposite Capital East Hill Advisors MVM Life Science Partners Novo Holdings Apposite Capital East Hill Advisors MVM Life Science Partners Novo Holdings |
---|
Announced Date | Name | Price |
---|---|---|
10/2007 | Surface Therapeutics Ltd. |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|